한글목차

증후성 멀티플렉스 진단 동향과 예측

세계 증후성 멀티플렉스 진단 시장은 2024년부터 2030년까지 7.5%의 CAGR로 2030년까지 약 42억 5,000만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 감염성 질환의 확산 증가, 분자 진단 기술의 채택 증가, 정확하고 빠른 결과와 치료에 대한 빠른 접근에 대한 수요 증가입니다. 세계 증후성 멀티플렉스 진단 시장의 미래는 병원 및 진단 실험실 시장에서의 비지니스 기회로 인해 유망합니다.

증후성 멀티플렉스 진단 시장 인사이트

Lucintel의 예측에 따르면, 소화기 계통은 위장염이나 식중독과 같은 질병을 유발하는 병원균을 식별하는 데 도움이 되기 때문에 예측 기간 동안 소화기 계통이 더 큰 부문을 차지할 것으로 예상됩니다.

이 시장 중 병원은 병원에서 진단 검사가 많기 때문에 병원이 가장 큰 시장으로 남을 것으로 예상됩니다.

북미 지역은 헬스케어 지출 증가, 조기 및 정확한 진단에 대한 수요 증가, 다양한 전염성 및 비전염성 질환의 유병률 증가로 인해 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 분야가 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 증후성 멀티플렉스 진단 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 증후성 멀티플렉스 진단 시장 동향(2018-2023)과 예측(2024-2030)
• 유형별 세계 증후성 멀티플렉스 진단 시장
  • 호흡기계
  • 소화기계
  • 중추신경계
  • 기타
• 최종 용도별 세계 증후성 멀티플렉스 진단 시장
  • 병원
  • 진단 연구소
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 증후성 멀티플렉스 진단 시장
• 북미의 증후성 멀티플렉스 진단 시장
• 유럽의 증후성 멀티플렉스 진단 시장
• 아시아태평양의 증후성 멀티플렉스 진단 시장
• 기타 지역의 증후성 멀티플렉스 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별 세계 증후성 멀티플렉스 진단 시장 성장 기회
  • 최종 용도별 세계 증후성 멀티플렉스 진단 시장 성장 기회
  • 지역별 세계의 증후성 멀티플렉스 진단 시장 성장 기회
• 세계의 증후성 멀티플렉스 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 증후성 멀티플렉스 진단 시장 능력 확대
  • 세계의 증후성 멀티플렉스 진단 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• BioMerieux
• Qiagen
• DiaSorin S.p.A
• Applied BioCode
• Akonni Biosystems
• Thermo Fisher Scientific
• Abbott Laboratories
• Accelerate Diagnostic
• Becton and Dickinson
• Hologic

영문목차

Syndromic Multiplex Diagnostic Trends and Forecast

The future of the global syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets. The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

A more than 150-page report is developed to help in your business decisions.

Syndromic Multiplex Diagnostic by Segment

The study includes a forecast for the global syndromic multiplex diagnostic by type, end use, and region.

Syndromic Multiplex Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Respiratory
• Gastrointestinal
• Central Nervous System
• Others

Syndromic Multiplex Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostics Laboratories
• Others

Syndromic Multiplex Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Syndromic Multiplex Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies syndromic multiplex diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the syndromic multiplex diagnostic companies profiled in this report include-

• Biomerieux
• Qiagen
• Diasorin S.P.A
• Applied Biocode
• Akonni Biosystems
• Thermo Fisher Scientific
• Abbott Laboratories
• Accelerate Diagnostic
• Becton and Dickinson
• Hologic

Syndromic Multiplex Diagnostic Market Insights

Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Within this market, hospitals is expected to remain the largest segment due to the high volume of diagnostic tests performed in hospitals.

North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Features of the Global Syndromic Multiplex Diagnostic Market

Market Size Estimates: Syndromic multiplex diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Syndromic multiplex diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Syndromic multiplex diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the syndromic multiplex diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the syndromic multiplex diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the syndromic multiplex diagnostic market size?

Answer: The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030.

Q2. What is the growth forecast for syndromic multiplex diagnostic market?

Answer: The global syndromic multiplex diagnostic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the syndromic multiplex diagnostic market?

Answer: The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

Q4. What are the major segments for syndromic multiplex diagnostic market?

Answer: The future of the syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets.

Q5. Who are the key syndromic multiplex diagnostic market companies?

Answer: Some of the key syndromic multiplex diagnostic companies are as follows:

• Biomerieux
• Qiagen
• Diasorin S.P.A
• Applied Biocode
• Akonni Biosystems
• Thermo Fisher Scientific
• Abbott Laboratories
• Accelerate Diagnostic
• Becton and Dickinson
• Hologic

Q6. Which syndromic multiplex diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Q7. In syndromic multiplex diagnostic market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the syndromic multiplex diagnostic market by type (respiratory, gastrointestinal, central nervous system, and others), end use (hospitals, diagnostics laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Syndromic Multiplex Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Syndromic Multiplex Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Syndromic Multiplex Diagnostic Market by Type
  • 3.3.1: Respiratory
  • 3.3.2: Gastrointestinal
  • 3.3.3: Central Nervous System
  • 3.3.4: Others
• 3.4: Global Syndromic Multiplex Diagnostic Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Diagnostics Laboratories
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Syndromic Multiplex Diagnostic Market by Region
• 4.2: North American Syndromic Multiplex Diagnostic Market
  • 4.2.2: North American Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
• 4.3: European Syndromic Multiplex Diagnostic Market
  • 4.3.1: European Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
  • 4.3.2: European Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
• 4.4: APAC Syndromic Multiplex Diagnostic Market
  • 4.4.1: APAC Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
  • 4.4.2: APAC Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
• 4.5: ROW Syndromic Multiplex Diagnostic Market
  • 4.5.1: ROW Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
  • 4.5.2: ROW Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by End Use
  • 6.1.3: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Syndromic Multiplex Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Syndromic Multiplex Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Syndromic Multiplex Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: BioMerieux
• 7.2: Qiagen
• 7.3: DiaSorin S.p.A
• 7.4: Applied BioCode
• 7.5: Akonni Biosystems
• 7.6: Thermo Fisher Scientific
• 7.7: Abbott Laboratories
• 7.8: Accelerate Diagnostic
• 7.9: Becton and Dickinson
• 7.10: Hologic